Background & Aims Patients with inflammatory bowel disease (IBD) frequently develop
extraintestinal manifestations (EIMs) that contribute substantially to morbidity. We assembled …

Background The clinical presentation of the inflammatory bowel diseases (IBD) is extremely
heterogenous and is characterized by various extraintestinal manifestations and …

Introduction: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily
of, but not restricted to the gut. Extraintestinal manifestations (EIMs) are frequently observed …

Abstract Background and Aims Genome-wide association studies [GWAS] for inflammatory
bowel disease [IBD] have identified 240 risk variants. However, the benefit of understanding …

OBJECTIVES: Estimates of familial risk of inflammatory bowel diseases (IBDs), Crohn's
disease (CD), and ulcerative colitis (UC) are needed for counseling of patients and could be …

Inflammatory bowel diseases (IBD) are characterized by idiopathic chronic inflammation of
the gastrointestinal tract, comprising the two major entities ulcerative colitis (UC) and …

Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), are progressive and disabling inflammatory disorders of the intestine. The precise …

Inflammatory bowel disease (IBD) is comprised of Crohn's disease (CD), characterized by
transmural inflammation involving the entire GI tract and ulcerative colitis (UC), which …

Background Over the last 2 decades, there has been an ever-expanding catalog of genetic
variants implicated in inflammatory bowel disease (IBD) through genome-wide association …

Background Extraintestinal manifestations (EIMs) in pediatric patients with inflammatory
bowel disease (IBD) are poorly characterized. We examined the prevalence of EIMs at …